Cardiology

Genetic testing for statin therapy not cost-effective

Current United States Preventive Service Task Force (USPSTF) guidelines call for screening all Americans between the ages of 40 and 75 years to determine eligibility for statins, a class of cholesterol-lowering medications. ...

Oncology & Cancer

Model including CRC risk alleles ups risk discrimination

(HealthDay)—Incorporation of a genetic risk score can improve the accuracy of colorectal cancer (CRC) risk determination, according to a study published in the June issue of Gastroenterology.

page 7 from 8